PMID- 34737592 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220428 IS - 1178-7007 (Print) IS - 1178-7007 (Electronic) IS - 1178-7007 (Linking) VI - 14 DP - 2021 TI - Cognitive Impairment and Related Factors Among Middle-Aged and Elderly Patients with Type 2 Diabetes from a Bio-Psycho-Social Perspective. PG - 4361-4369 LID - 10.2147/DMSO.S333373 [doi] AB - OBJECTIVE: This study investigated the biomedical, psychological, and social behavior risk factors for cognitive impairment in middle-aged and elderly patients with type 2 diabetes mellitus (T2DM). METHODS: This cross-sectional study included 240 patients with T2DM. A questionnaire was used to collect demographic and disease-related data on patients, and the Self-rating Depression Scale (SDS), Diabetes Self-care Scale (DSCS), and Social Support Rating Scale (SSRS) were used to assess patients' depression status, self-management behavior, and social support, respectively. The Chinese version of the Montreal Cognitive Assessment (MoCA) was used to evaluate cognitive function, with a score <26 set as the threshold for cognitive impairment. RESULTS: The prevalence of cognitive dysfunction in middle-aged and elderly patients with T2DM was 52.5%. Multivariate logistic regression analysis showed that older age, a history of hypoglycemia within 1 month, and depression were independent risk factors for cognitive impairment. Education for >12 years, urban living, and a higher total score on the DSCS were independent protective factors against cognitive impairment. CONCLUSION: T2DM patients with high risk of cognitive impairment can be identified early from the bio-psycho-social perspective. Patients with T2DM who are older, less educated, living in rural areas, have hypoglycemia history, and have poor self-management of diabetes are at increased risk of cognitive impairment. Closer monitoring of patients with hypoglycemia, early detection of depression, and improving patients' self-management capacity can prevent cognitive impairment in middle-aged and elderly patients with T2DM. CI - (c) 2021 Xu et al. FAU - Xu, Weiran AU - Xu W AUID- ORCID: 0000-0001-8837-2914 AD - School of Nursing, Sun Yat-sen University, Guangzhou, People's Republic of China. FAU - Hu, Xiling AU - Hu X AUID- ORCID: 0000-0001-7888-2267 AD - Department of Medicine, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, People's Republic of China. FAU - Zhang, Xing AU - Zhang X AD - Department of Endocrinology and Metabolism, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, People's Republic of China. FAU - Ling, Cong AU - Ling C AD - Department of Neurosurgery, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, People's Republic of China. FAU - Wang, Chaofan AU - Wang C AD - Department of Endocrinology and Metabolism, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, People's Republic of China. FAU - Gao, Lingling AU - Gao L AUID- ORCID: 0000-0002-0159-4344 AD - School of Nursing, Sun Yat-sen University, Guangzhou, People's Republic of China. LA - eng PT - Journal Article DEP - 20211028 PL - New Zealand TA - Diabetes Metab Syndr Obes JT - Diabetes, metabolic syndrome and obesity : targets and therapy JID - 101515585 PMC - PMC8560081 OTO - NOTNLM OT - cognitive impairment OT - depression OT - self-care OT - social support OT - type 2 diabetes mellitus COIS- The authors report no conflicts of interest in this work. EDAT- 2021/11/06 06:00 MHDA- 2021/11/06 06:01 PMCR- 2021/10/28 CRDT- 2021/11/05 06:46 PHST- 2021/08/14 00:00 [received] PHST- 2021/10/15 00:00 [accepted] PHST- 2021/11/05 06:46 [entrez] PHST- 2021/11/06 06:00 [pubmed] PHST- 2021/11/06 06:01 [medline] PHST- 2021/10/28 00:00 [pmc-release] AID - 333373 [pii] AID - 10.2147/DMSO.S333373 [doi] PST - epublish SO - Diabetes Metab Syndr Obes. 2021 Oct 28;14:4361-4369. doi: 10.2147/DMSO.S333373. eCollection 2021.